138 related articles for article (PubMed ID: 23342286)
1. Measuring colorectal cancer care quality for the publicly insured in New York State.
Sinclair AH; Schymura MJ; Boscoe FP; Yung RL; Chen K; Roohan P; Tai E; Schrag D
Cancer Med; 2012 Dec; 1(3):363-71. PubMed ID: 23342286
[TBL] [Abstract][Full Text] [Related]
2. Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California.
Mack JW; Chen K; Boscoe FP; Gesten FC; Roohan PJ; Weeks JC; Schymura MJ; Schrag D
J Clin Oncol; 2013 Jul; 31(20):2569-79. PubMed ID: 23733768
[TBL] [Abstract][Full Text] [Related]
3. Clinical, sociodemographic, and service provider determinants of guideline concordant colorectal cancer care for Appalachian residents.
Fleming ST; Mackley HB; Camacho F; Seiber EE; Gusani NJ; Matthews SA; Liao J; Yang TC; Hwang W; Yao N
J Rural Health; 2014; 30(1):27-39. PubMed ID: 24383482
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
5. Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
Tsui J; DeLia D; Stroup AM; Nova J; Kulkarni A; Ferrante JM; Cantor JC
Cancer; 2019 Apr; 125(8):1330-1340. PubMed ID: 30561793
[TBL] [Abstract][Full Text] [Related]
6. Disparities in colorectal cancer stage of diagnosis among Medicaid-insured residents of North Carolina.
Snyder JW; Foley KL
N C Med J; 2010; 71(3):206-12. PubMed ID: 20681486
[TBL] [Abstract][Full Text] [Related]
7. Health care factors related to stage at diagnosis and survival among Medicare patients with colorectal cancer.
Lee-Feldstein A; Feldstein PJ; Buchmueller T
Med Care; 2002 May; 40(5):362-74. PubMed ID: 11961471
[TBL] [Abstract][Full Text] [Related]
8. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
[TBL] [Abstract][Full Text] [Related]
9. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
[TBL] [Abstract][Full Text] [Related]
10. Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
Schrag D; Cramer LD; Bach PB; Begg CB
J Natl Cancer Inst; 2001 Jun; 93(11):850-7. PubMed ID: 11390534
[TBL] [Abstract][Full Text] [Related]
11. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders.
Baldwin LM; Schneider JL; Schwartz M; Rivelli JS; Green BB; Petrik AF; Coronado GD
BMC Health Serv Res; 2020 Feb; 20(1):132. PubMed ID: 32085767
[TBL] [Abstract][Full Text] [Related]
12. Improving Adjuvant Hormone Therapy Use in Medicaid Managed Care-Insured Women, New York State, 2012-2014.
Wagner VL; Jing W; Boscoe FP; Schymura MJ; Roohan PJ; Gesten FC
Prev Chronic Dis; 2016 Sep; 13():E120. PubMed ID: 27584876
[TBL] [Abstract][Full Text] [Related]
13. Screening colonoscopy among colorectal cancer survivors insured by Medicaid.
Foley KL; Song EY; Klepin H; Geiger A; Tooze J
Am J Clin Oncol; 2012 Jun; 35(3):205-11. PubMed ID: 21358299
[TBL] [Abstract][Full Text] [Related]
14. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
[TBL] [Abstract][Full Text] [Related]
15. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
[TBL] [Abstract][Full Text] [Related]
16. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
[TBL] [Abstract][Full Text] [Related]
17. Association of Delays in Surgery for Melanoma With Insurance Type.
Adamson AS; Zhou L; Baggett CD; Thomas NE; Meyer AM
JAMA Dermatol; 2017 Nov; 153(11):1106-1113. PubMed ID: 28979974
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
[TBL] [Abstract][Full Text] [Related]
19. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
[TBL] [Abstract][Full Text] [Related]
20. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program.
Green BB; West II; Baldwin LM; Schwartz MR; Coury J; Coronado GD
J Community Health; 2020 Oct; 45(5):916-921. PubMed ID: 32219712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]